Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)

NCT00916942 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia

Interventions

DRUG: capsaicin 8%
DRUG: Lidocaine (2.5%)/Prilocaine (2.5%) Cream

Sponsor

NeurogesX